October 21 - 23, 2024
Presented in Japan Standard TimeThe Westin Miyako Kyoto
Delivered as a Hybrid Event
Makoto NakayamaDirector, Antibody & Biologics Group at Kyowa KirinSpeaker
Profile
Makoto Nakayama has over 15 years antibody technology and product development experiences. He has been engaged in the study of establishing and applying the REGULGENTTM bispecific antibody technology. He currently works as Director of Antibody & Biologics Group in Research Core Function Laboratories at Kyowa Kirin Co., Ltd., leading antibody and biologics discovery and laboratory automation.
Agenda Sessions
Novel Bispecific Antibody Format with Reliable Productivity and Developability and Its Product Application
, 15:30View Session